Literature DB >> 9215148

Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.

Z Szekanecz1, G K Haines, A E Koch.   

Abstract

AIM: To determine whether the urokinase plasminogen activator receptor (u-PAR; CD87) exhibits a possible pathogenic role in rheumatoid and osteoarthritis.
METHODS: A semiquantitative, indirect immunoperoxidase histochemical analysis was performed on frozen synovial tissue sections. The recently characterised monoclonal antibody 10G7 recognising transfectants bearing u-PAR was used. Synovial tissue was obtained from 10 patients with rheumatoid arthritis, 10 patients with osteoarthritis, and four normal subjects.
RESULTS: u-PAR was expressed on 70-90% of synovial tissue lining cells and subsynovial, interstitial macrophages from the arthritis patients, but only on a few myeloid cells from the normal subjects. It was also present on more endothelial cells from the rheumatoid and osteoarthritis patients, than from normal synovial tissue.
CONCLUSIONS: Plasminogen activators are important in joint destruction underlying arthritis. The up-regulated expression of u-PAR in diseased versus normal synovial tissue suggests a role for this antigen in the inflammatory and angiogenic mechanisms underlying rheumatoid and osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215148      PMCID: PMC499882          DOI: 10.1136/jcp.50.4.314

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  49 in total

1.  Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis.

Authors:  R H Goldfarb; M Ziche; G Murano; L A Liotta
Journal:  Semin Thromb Hemost       Date:  1986-10       Impact factor: 4.180

2.  IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes.

Authors:  J C Kirchheimer; Y H Nong; H G Remold
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

3.  Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo.

Authors:  M D Boyle; V A Chiodo; M J Lawman; A P Gee; M Young
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.

Authors:  H Y Min; L V Doyle; C R Vitt; C L Zandonella; J R Stratton-Thomas; M A Shuman; S Rosenberg
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

6.  The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.

Authors:  R G Sitrin; R F Todd; E Albrecht; M R Gyetko
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  Plasminogen activator in synovial fluid from patients with rheumatoid arthritis.

Authors:  H Kikuchi; S Tanaka; O Matsuo
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

9.  Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.

Authors:  H K Ronday; H H Smits; G N Van Muijen; M S Pruszczynski; R J Dolhain; E J Van Langelaan; F C Breedveld; J H Verheijen
Journal:  Br J Rheumatol       Date:  1996-05

10.  Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.

Authors:  V Magdolen; P Rettenberger; M Koppitz; L Goretzki; H Kessler; U H Weidle; B König; H Graeff; M Schmitt; O Wilhelm
Journal:  Eur J Biochem       Date:  1996-05-01
View more
  5 in total

1.  Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis.

Authors:  O Slot; N Brünner; H Locht; P Oxholm; R W Stephens
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Authors:  Morten Persson; Dorthe Skovgaard; Malene Brandt-Larsen; Camilla Christensen; Jacob Madsen; Carsten H Nielsen; Tine Thurison; Thomas Levin Klausen; Søren Holm; Annika Loft; Anne Kiil Berthelsen; Michael Ploug; Helle Pappot; Klaus Brasso; Niels Kroman; Liselotte Højgaard; Andreas Kjaer
Journal:  Theranostics       Date:  2015-09-13       Impact factor: 11.556

Review 3.  The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.

Authors:  Benjamin J Buckley; Umar Ali; Michael J Kelso; Marie Ranson
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

Review 4.  Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.

Authors:  V M Baart; R D Houvast; L F de Geus-Oei; P H A Quax; P J K Kuppen; A L Vahrmeijer; C F M Sier
Journal:  EJNMMI Res       Date:  2020-07-28       Impact factor: 3.138

Review 5.  Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky.

Authors:  Jim Middleton; Laure Americh; Regis Gayon; Denis Julien; Luc Aguilar; Francois Amalric; Jean-Philippe Girard
Journal:  Arthritis Res Ther       Date:  2004-03-08       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.